-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
GE Healthcare, Philips Healthcare, and Siemens Healthcare, these three companies are collectively known as GPS, large companies in the medical equipment field.
With the release of 2021 financial reports, these three companies also announced their own 2021 financial reports, then in 2021 the performance of these three companies will be What changes? Siemens Healthineer's revenue of 18 billion euros Siemens Healthineer is mainly composed of four major business segments: imaging, diagnosis, clinical treatment and Varian
.
In fiscal 2021, Siemens Healthineers' total revenue increased by 24% year-on-year to 18 billion euros
.
In fiscal 2021, Siemens Healthineers' R&D expenses increased by 15% to approximately $1.
746 billion
.
In the specific business segment, the revenue of Siemens' medical imaging business increased by 8% year-on-year to 9.
821 billion euros, accounting for 54.
6% of the total revenue; the revenue of the diagnostic business increased by 38% year-on-year to 5.
418 billion euros; the revenue of the clinical treatment business was year-on-year.
An increase of 5% to 1.
716 billion euros
.
Siemens Healthineers said it raised its guidance for fiscal 2022
.
The company's overall revenue for the full year is expected to grow between 3% and 5% year-on-year
.
According to the performance data of the first quarter of fiscal year 2022 (October 1, 2021 to December 31, 2021) released by Siemens Healthineers recently, Siemens Healthineers revenue in the first quarter of fiscal year 2022 increased by 9.
5% year-on-year, and the equipment order-to-shipment ratio up to 1.
20
.
Among them, the revenue of the laboratory diagnosis business increased by 19.
7% year-on-year, showing excellent performance; Varian had a solid start to the new fiscal year, contributing 750 million euros in revenue; the imaging business maintained a strong momentum, with revenue increasing by 5.
9% year-on-year; clinical treatment business revenue Revenue rose 3.
3% year-on-year
.
GE Healthcare's revenue of $17.
7 billion GE Healthcare is accelerating its own business focus to better empower clinical practice
.
Recently, GE released its 2021 annual report, and GE Healthcare achieved annual revenue of $17.
7 billion
.
Among them, the medical system (referred to as HCS, including imaging, ultrasound, life care solutions, enterprise software and solutions, referred to as HCS) revenue increased by 2% year-on-year to $15.
7 billion, accounting for 89% of GE Healthcare's total revenue
.
Pharmaceutical Diagnostics (PDx for short, which includes contrast agents and nuclear tracers) revenue rose 13% year over year to $2 billion, accounting for 11% of GE Healthcare's total revenue
.
It is understood that in 2021, GE Healthcare will begin to make great strides in the field of precision medicine
.
For example, in 2021, GE Healthcare acquired BK Medical, a manufacturer of advanced surgical visualization technology
.
BK Medical has technology that helps clinicians observe the inside of a patient's body in real-time during surgery, which can help improve treatment outcomes, speed up surgery and reduce complications
.
This complementary acquisition will help GE Healthcare expand its ultrasound business with annual revenue of up to $3 billion from diagnosis to procedures such as surgery, and help GE Healthcare bring more innovative products in the field of advanced surgical visualization to accelerate the development of precision medicine
.
In 2021, GE Healthcare also launched a new pocket-sized color ultrasound scanner, the Vscan Air, a handheld wireless device that transmits images detected by ultrasound probes to a smartphone app
.
Philips' medical business revenue is 13.
23 billion euros.
In 2021, Philips' total revenue is 17.
156 billion euros, and its medical business (only considering diagnosis and treatment and connected care business) revenue is 13.
23 billion euros
.
Among them, the revenue of Philips medical diagnosis and treatment business increased by 6% year-on-year to 8.
635 billion euros; the revenue of connected care business decreased by 18% year-on-year to 4.
593 billion euros
.
Philips, founded in the Netherlands in 1891 as a light bulb maker, has shifted its focus to healthcare over the past decade and spun off its lighting business in 2016, according to the data
.
Philips Medical's products include a variety of imaging systems and diagnostic products
.
Philips Healthcare has made a big splash in cardiac monitoring with two major acquisitions in 2021
.
The company paid $2.
8 billion for biotelemetry and arrhythmia diagnosis and monitoring systems, acquiring Cardiologs and its artificial intelligence (AI)-based cardiac diagnostic technology for an undisclosed amount
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
With the release of 2021 financial reports, these three companies also announced their own 2021 financial reports, then in 2021 the performance of these three companies will be What changes? Siemens Healthineer's revenue of 18 billion euros Siemens Healthineer is mainly composed of four major business segments: imaging, diagnosis, clinical treatment and Varian
.
In fiscal 2021, Siemens Healthineers' total revenue increased by 24% year-on-year to 18 billion euros
.
In fiscal 2021, Siemens Healthineers' R&D expenses increased by 15% to approximately $1.
746 billion
.
In the specific business segment, the revenue of Siemens' medical imaging business increased by 8% year-on-year to 9.
821 billion euros, accounting for 54.
6% of the total revenue; the revenue of the diagnostic business increased by 38% year-on-year to 5.
418 billion euros; the revenue of the clinical treatment business was year-on-year.
An increase of 5% to 1.
716 billion euros
.
Siemens Healthineers said it raised its guidance for fiscal 2022
.
The company's overall revenue for the full year is expected to grow between 3% and 5% year-on-year
.
According to the performance data of the first quarter of fiscal year 2022 (October 1, 2021 to December 31, 2021) released by Siemens Healthineers recently, Siemens Healthineers revenue in the first quarter of fiscal year 2022 increased by 9.
5% year-on-year, and the equipment order-to-shipment ratio up to 1.
20
.
Among them, the revenue of the laboratory diagnosis business increased by 19.
7% year-on-year, showing excellent performance; Varian had a solid start to the new fiscal year, contributing 750 million euros in revenue; the imaging business maintained a strong momentum, with revenue increasing by 5.
9% year-on-year; clinical treatment business revenue Revenue rose 3.
3% year-on-year
.
GE Healthcare's revenue of $17.
7 billion GE Healthcare is accelerating its own business focus to better empower clinical practice
.
Recently, GE released its 2021 annual report, and GE Healthcare achieved annual revenue of $17.
7 billion
.
Among them, the medical system (referred to as HCS, including imaging, ultrasound, life care solutions, enterprise software and solutions, referred to as HCS) revenue increased by 2% year-on-year to $15.
7 billion, accounting for 89% of GE Healthcare's total revenue
.
Pharmaceutical Diagnostics (PDx for short, which includes contrast agents and nuclear tracers) revenue rose 13% year over year to $2 billion, accounting for 11% of GE Healthcare's total revenue
.
It is understood that in 2021, GE Healthcare will begin to make great strides in the field of precision medicine
.
For example, in 2021, GE Healthcare acquired BK Medical, a manufacturer of advanced surgical visualization technology
.
BK Medical has technology that helps clinicians observe the inside of a patient's body in real-time during surgery, which can help improve treatment outcomes, speed up surgery and reduce complications
.
This complementary acquisition will help GE Healthcare expand its ultrasound business with annual revenue of up to $3 billion from diagnosis to procedures such as surgery, and help GE Healthcare bring more innovative products in the field of advanced surgical visualization to accelerate the development of precision medicine
.
In 2021, GE Healthcare also launched a new pocket-sized color ultrasound scanner, the Vscan Air, a handheld wireless device that transmits images detected by ultrasound probes to a smartphone app
.
Philips' medical business revenue is 13.
23 billion euros.
In 2021, Philips' total revenue is 17.
156 billion euros, and its medical business (only considering diagnosis and treatment and connected care business) revenue is 13.
23 billion euros
.
Among them, the revenue of Philips medical diagnosis and treatment business increased by 6% year-on-year to 8.
635 billion euros; the revenue of connected care business decreased by 18% year-on-year to 4.
593 billion euros
.
Philips, founded in the Netherlands in 1891 as a light bulb maker, has shifted its focus to healthcare over the past decade and spun off its lighting business in 2016, according to the data
.
Philips Medical's products include a variety of imaging systems and diagnostic products
.
Philips Healthcare has made a big splash in cardiac monitoring with two major acquisitions in 2021
.
The company paid $2.
8 billion for biotelemetry and arrhythmia diagnosis and monitoring systems, acquiring Cardiologs and its artificial intelligence (AI)-based cardiac diagnostic technology for an undisclosed amount
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
